Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The retinoid receptors

S M Pemrick1, D A Lucas, J F Grippo

  • 1Department of Toxicology and Pathology, Hoffmann-La Roche, Nutley, NJ 07110.

Leukemia
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Retinoid receptors are crucial for gene regulation and have therapeutic uses in dermatology and oncology. However, resistance can develop due to mutations or pharmacokinetic issues, posing challenges for drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanoma.

Cancer chemotherapy and pharmacology·2013
Same author

Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment.

Antimicrobial agents and chemotherapy·2013
Same author

The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C.

Alimentary pharmacology & therapeutics·2012
Same author

Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2010
Same author

Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes.

Diabetes·2001
Same author

Characterization of glucokinase regulatory protein-deficient mice.

The Journal of biological chemistry·2000

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Retinoid receptors are ligand-inducible transcription factors integral to cellular processes.
  • They share structural similarities with other nuclear receptors like steroid and thyroid hormone receptors.
  • Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) exist in multiple subtypes and isoforms, regulating distinct gene pathways.

Purpose of the Study:

  • To explore the role of retinoid receptors in gene regulation and their clinical applications.
  • To investigate the mechanisms of retinoid resistance encountered in clinical and experimental settings.
  • To identify challenges and potential strategies for overcoming retinoid resistance in drug discovery.

Main Methods:

  • Review of existing literature on retinoid receptor structure, function, and gene regulation.

Related Experiment Videos

  • Analysis of data linking retinoid resistance to RAR gene mutations and dominant-negative activity.
  • Discussion of pharmacokinetic factors contributing to retinoid resistance in acute promyelocytic leukemia (APL).

    • Main Results:

    • Mutated RAR receptors can exhibit dominant-negative activity, interfering with normal transcription.
    • Retinoid resistance is associated with RAR gene mutations and pharmacokinetic problems, such as decreasing plasma retinoic acid levels.
    • Heterodimerization of RXR with other nuclear receptors influences gene pathways critical for growth and differentiation.

    Conclusions:

    • Retinoids are valuable in dermatology and oncology, but resistance is a significant clinical challenge.
    • Understanding the molecular basis of retinoid resistance, including dominant-negative effects and pharmacokinetics, is crucial.
    • Future drug discovery efforts should focus on circumventing resistance mechanisms, potentially through novel drug delivery or alternative retinoid compounds.